Steadybase.

Covista Inc.

Website Investor relations LinkedIn Latest 10-K
  • CVSA · NYSE
  • Services-Educational Services
  • Chicago, IL
  • CIK 0000730464

Updated from SEC filings through

Top things to know

Executives

What leadership is saying

“Purpose at Scale is delivering and all four pillars of the strategy are contributing to our momentum. Total enrollment grew for the 13th consecutive quarter, powering our double-digit revenue growth and continued margin expansion. On that strength, we are raising our fiscal 2027 guidance”

Steve Beard, Chairman and Chief Executive Officer, Covista
Earnings press release (8-K Ex. 99.1), filed October 29, 2026

Covista Inc. is a U.S. public company in services-educational services (SIC 8200), headquartered in Chicago, IL. It trades as CVSA on NYSE. Revenue was $2.0B in the fiscal year ending June 30, 2026, +9.3% from the year before. Steve Beard is Chairman and Chief Executive Officer, Covista.

Five-year financials

MetricFY2026FY2025FY2024FY2023FY2022
Revenue $2.0B
10-K, 2026-08-06
$1.8B
10-K, 2026-08-06
$1.6B
10-K, 2026-08-06
$1.5B
10-K, 2025-08-07
$1.4B
10-K, 2024-08-06
Operating income $383M
10-K, 2026-08-06
$342M
10-K, 2026-08-06
$217M
10-K, 2026-08-06
$168M
10-K, 2025-08-07
$76.7M
10-K, 2024-08-06
SG&A $731M
10-K, 2026-08-06
$672M
10-K, 2026-08-06
$633M
10-K, 2026-08-06
$586M
10-K, 2025-08-07
$566M
10-K, 2024-08-06
Net income $252M
10-K, 2026-08-06
$237M
10-K, 2026-08-06
$137M
10-K, 2026-08-06
$93.4M
10-K, 2025-08-07
$311M
10-K, 2024-08-06

Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.

Leadership and board

NameTitleSource
Steve Beard Chairman and Chief Executive Officer, Covista 8-K, 2026-10-29
Stephen W. Beard Chairman & CEO 4, 2026-08-25
Robert J. Phelan
Chief Financial Officer at Covista, America’s largest healthcare educator
Chief Financial Officer 4, 2026-08-25
Manjunath Gangadharan VP, Chief Accounting Officer 4, 2026-08-28
Amelia Manning Amelia Manning
President of Chamberlain University at Covista, America’s largest healthcare educator
President, Chamberlain University 10-K, 2026-08-06
Megan Noel Megan Noel Senior Vice President, Chief Corporate Affairs Officer 10-K, 2026-08-06
Sara Hill Sara Hill
CHRO at Covista, America’s largest healthcare educator
Senior Vice President, Chief Human Resources Officer 10-K, 2026-08-06
Scott Liles Scott Liles
President, Medical and Veterinary and Chief Strategy and Performance Officer at Covista
Chief Strategy and Performance Officer and President, Medical and Veterinary 10-K, 2026-08-06
Karen Sue Cox President, Chamberlain Univ. 4, 2026-05-12
Evan Trent President, Adtalem Elevate 4, 2025-11-14
Maurice Herrera SVP - Chief Marketing Officer 4, 2025-11-14
Douglas G. Beck Douglas G. Beck
General Counsel, Corporate Secretary, and Institutional Support Services at Covista, America’s largest healthcare educator
SVP, GC, Corp. Sec & ISS 4, 2026-08-25
Michael Betz Michael Betz
Chief Growth & Innovation Officer at Covista and President of Walden University
Pres. Walden University & CDO 4, 2026-08-25
Betty Vandenbosch Director 10-K, 2026-08-06
Donna J. Hrinak Director 10-K, 2026-08-06
Georgette Kiser Director 10-K, 2026-08-06

What Covista Inc. does

Covista is America’s largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University (“Chamberlain”), Walden University (“Walden”), American University of the Caribbean School of Medicine (“AUC”), Ross University School of Medicine (“RUSM”), and Ross University School of Veterinary Medicine (“RUSVM”). Covista delivers education to its students at multiple campuses and online.

Item 1. Business, 10-K for the year ending June 30, 2026

Shares and governance

Shares outstanding 33.3 million (as of October 23, 2026) 10-Q, October 29, 2026
Public float $3.5B (as of December 31, 2025) 10-K, August 6, 2026
Reportable segments 3 (period ending September 30, 2026) 10-Q, October 29, 2026
Latest proxy statement Meeting November 11, 2026 (filed October 2, 2026) DEF 14A, October 2, 2026
Auditor PricewaterhouseCoopers LLP (Chicago, Illinois) Latest 10-K

Insider trades

Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.

DateInsiderTradeSharesValueSource
October 9, 2026 Stephen W. Beard
Chairman & CEO
Sale 8,306 $1.1M Form 4, October 9, 2026
August 27, 2026 Manjunath Gangadharan
VP, Chief Accounting Officer
Sale 1,802 $247K Form 4, August 28, 2026
August 11, 2026 Stephen W. Beard
Chairman & CEO
Sale 3,545 $462K Form 4, August 13, 2026
August 7, 2026 Robert J. Phelan
Chief Financial Officer
Sale 2,186 $295K Form 4, August 11, 2026
August 7, 2026 Douglas G. Beck
SVP, GC, Corp. Sec & ISS
Sale 4,526 $615K Form 4, August 11, 2026
July 13, 2026 Stephen W. Beard
Chairman & CEO
Sale 5,291 $702K Form 4, July 15, 2026
July 8, 2026 Robert J. Phelan
Chief Financial Officer
Sale 5,314 $720K Form 4, July 9, 2026
July 8, 2026 Douglas G. Beck
SVP, GC, Corp. Sec & ISS
Sale 5,089 $689K Form 4, July 9, 2026

Recent 8-K events

  • 8-K filed 2026-10-29
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-09-23
    • Item 1.01 Entry into a material definitive agreement
    • Item 2.03 Creation of a direct financial obligation
  • 8-K filed 2026-08-06
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-07-28
    • Item 5.02 Departure or appointment of directors or officers; compensation
  • 8-K filed 2026-05-07
    • Item 2.02 Results of operations and financial condition (earnings release)
  • 8-K filed 2026-04-09
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-03-03
    • Item 1.01 Entry into a material definitive agreement
    • Item 1.02 Termination of a material definitive agreement
    • Item 2.03 Creation of a direct financial obligation
  • 8-K filed 2026-02-24
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-02-06
    • Item 5.03 Amendments to articles or bylaws; change in fiscal year
    • Item 7.01 Regulation FD disclosure
  • 8-K filed 2026-01-28
    • Item 2.02 Results of operations and financial condition (earnings release)

Frequently asked questions about Covista Inc.

What does Covista Inc. do?
In its own words, from Item 1 of its 10-K: "Covista is America’s largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University (“Chamberlain”), Walden University (“Walden”), American University of the Caribbean School of Medicine (“AUC”), Ross University School of Medicine (“RUSM”), and Ross University School of Veterinary Medicine (“RUSVM”). Covista delivers education to its students at multiple campuses and online."
What is Covista Inc.'s revenue?
$2.0B for the fiscal year ending June 30, 2026, from its 10-K filed August 6, 2026.
Is Covista Inc. profitable?
Covista Inc. reported net income of $252M for the fiscal year ending June 30, 2026.
Who is the CEO of Covista Inc.?
Steve Beard, Chairman and Chief Executive Officer, Covista, as named in a 8-K filed October 29, 2026.
Who is the CFO of Covista Inc.?
Robert J. Phelan, Chief Financial Officer, as named in a 4 filed August 25, 2026.
Where is Covista Inc. headquartered?
Chicago, IL.
What is Covista Inc.'s stock ticker?
CVSA on NYSE.
What industry is Covista Inc. in?
Services-Educational Services, SIC code 8200.
What is Covista Inc.'s website?
covista.com. Investor relations: https://investors.covista.com/overview/default.aspx.
When does Covista Inc. report earnings next?
January 27, 2027. Source: estimate_8k_pattern.
Is Covista Inc. a public company?
Yes. Covista Inc. files with the SEC under CIK 0000730464 and trades as CVSA.
Who audits Covista Inc.?
PricewaterhouseCoopers LLP, Chicago, Illinois, as named in its latest annual report (10-K).
How many shares of Covista Inc. are outstanding?
33.3 million shares as of October 23, 2026, from its 10-Q filed October 29, 2026.
What is Covista Inc.'s public float?
$3.5B as of December 31, 2025, as reported on the cover of its 10-K filed August 6, 2026.
How many business segments does Covista Inc. report?
3 reportable segments for the period ending September 30, 2026, from its 10-Q filed October 29, 2026.
When is Covista Inc.'s annual shareholder meeting?
November 11, 2026, per its proxy statement (DEF 14A) filed October 2, 2026.
Have Covista Inc. insiders traded stock recently?
Since August 21, 2025, officers and directors reported 17 open-market sales worth about $18.0M and 4 purchases worth about $3.9M on Forms 4 and 5. The most recent: Stephen W. Beard (Chairman & CEO) sold 8,306 shares on October 9, 2026.